How to transfer my Mounjaro prescription to Illinois

If you’re considering medications like Wegovy, Ozempic, or Mounjaro for weight loss, you’ve probably wondered: Can I get these prescribed online through telehealth? The short answer is yes—in most cases, you can legally access GLP-1 weight loss medications via telehealth in the United States. But as with many healthcare questions, the details matter.

This comprehensive guide breaks down everything you need to know about getting weight loss medications through telehealth in 2025, including federal regulations, state-by-state differences, provider qualifications, and what to expect during your virtual consultation.

Understanding Federal Telehealth Rules for Weight Loss Medications

The good news: Federal law does not require an in-person visit before prescribing GLP-1 weight loss medications like Wegovy, Ozempic, or Mounjaro through telehealth.

Here’s why: These medications are not controlled substances under the Controlled Substances Act. The Ryan Haight Act—which typically requires an in-person exam before prescribing certain medications via telemedicine—only applies to controlled substances like Adderall or opioids. Since semaglutide (Wegovy/Ozempic) and tirzepatide (Mounjaro) don’t fall into this category, they can be prescribed remotely without federal restrictions.

Current Federal Status (December 2025)

The Drug Enforcement Administration (DEA) has extended COVID-era telehealth flexibilities for controlled substances through December 31, 2025. While this doesn’t directly affect non-controlled GLP-1 medications, it reflects the federal government’s ongoing support for expanded telehealth access.

Key takeaway: From a federal perspective, there are no special barriers preventing you from getting weight loss medications prescribed via telehealth, as long as you’re working with a properly licensed provider.

Free consultations available with select providers only.

Get a free consultation

And find an affordable, caring specialist.

Find a provider

Free consultations available with select providers only.

How Telehealth Weight Loss Prescribing Actually Works

When you seek weight loss medication through telehealth, you can expect a process that mirrors in-person care—just conducted remotely. Here’s what typically happens:

Initial Consultation

Your provider will conduct a comprehensive medical evaluation via live video. This includes:

• Detailed medical history review
• Current medications and allergies
• Height, weight, and BMI calculation
• Discussion of previous weight loss attempts
• Screening for contraindications (like personal or family history of medullary thyroid cancer)
• Assessment of co-existing conditions (diabetes, hypertension, etc.)

Clinical Eligibility

Reputable telehealth providers follow FDA-approved prescribing criteria. Generally, you may be a candidate if you:

• Have a BMI of 30 or higher (obesity), OR
• Have a BMI of 27 or higher with weight-related health conditions (like type 2 diabetes, high blood pressure, or sleep apnea)
• Have attempted lifestyle modifications (diet and exercise)
• Don’t have contraindications to GLP-1 therapy

Treatment Plan and Prescription

If you qualify, your provider will:

• Discuss medication options, expected results, and potential side effects
• Create a comprehensive treatment plan including dietary and exercise recommendations
• Send an electronic prescription to your preferred pharmacy
• Schedule follow-up appointments to monitor progress

Ongoing Monitoring

Weight loss medication isn’t a ‘set it and forget it’ treatment. Most telehealth providers require:

• Regular check-ins (typically every 1-3 months)
• Weight and side effect tracking
• Periodic lab work to ensure safety
• Dose adjustments as needed

At Klarity Health, our providers take this comprehensive approach seriously, ensuring you receive safe, effective care with transparent pricing—whether you’re using insurance or paying cash.

State-Specific Requirements: What You Need to Know

While federal law allows telehealth prescribing of GLP-1 medications, individual states add their own requirements. Some states are very flexible, while others require additional steps.

States With No In-Person Requirement

Several states allow you to complete your entire weight loss treatment journey via telehealth without ever visiting a physical office:

California, Illinois, New York, Pennsylvania, Washington—These states have fully embraced telehealth for non-controlled medications. A video consultation establishes a valid patient-provider relationship, and prescriptions can be issued without an in-person exam.

States Requiring Initial In-Person Evaluation

Other states mandate an in-person physical examination before or shortly after starting telehealth treatment:

Arkansas, Delaware, Georgia, Mississippi, New Jersey, North Dakota, South Carolina, Texas, Utah, Virginia—These states require providers to perform an initial hands-on evaluation. This might include:

• Physical examination
• Baseline laboratory work (metabolic panel, thyroid function, etc.)
• In-person assessment of overall health

If you live in one of these states, you’ll typically need to visit a local healthcare provider for your initial evaluation, then transition to telehealth for ongoing management.

States With Special Prescribing Protocols

Some states impose additional requirements for prescribing weight loss medications:

Florida requires that patients:

• Have a BMI of 30 or higher
• Receive follow-up evaluations at least every 3 months during treatment
• Be provided with diet and exercise counseling

Connecticut mandates that obesity treatment include behavioral counseling alongside medication.

New Jersey and Virginia require comprehensive initial work-ups including physical exam, laboratory tests, psychological screening, and documented diet/exercise plans.

A Quick State Comparison

Here’s how telehealth prescribing works in select states:

Note: Even in states requiring initial in-person visits, many patients can find local providers for that first appointment, then transfer to telehealth platforms for ongoing care.

Provider Qualifications: Who Can Prescribe via Telehealth?

Understanding who can prescribe weight loss medications helps you evaluate telehealth services.

Physicians (MDs and DOs)

Medical doctors and doctors of osteopathy can prescribe GLP-1 medications via telehealth in all states, provided they’re licensed where you’re located.

Nurse Practitioners (NPs)

Nurse practitioners are increasingly important in telehealth weight loss care. However, their prescribing authority varies significantly by state:

Full Independent Practice States (34 states + DC as of 2025): NPs can evaluate patients and prescribe medications without physician oversight. Examples include:

• Washington, California, New York
• Arizona, Colorado, Connecticut
• Illinois, Maryland, Michigan

Collaborative Practice States: NPs can prescribe but must have a formal agreement with a supervising physician. Examples include:

• Florida, Georgia, Pennsylvania
• Texas, Mississippi, South Carolina

Restricted Practice States (very few): NPs have limited prescribing authority even with physician collaboration.

Physician Assistants (PAs)

PAs can prescribe GLP-1 medications in all states, but typically require a supervising physician relationship. The level of autonomy varies—some states allow very independent practice, while others require close oversight.

Important note: Working with an NP or PA for your telehealth weight loss care is completely legitimate and often advantageous, as these providers typically have more availability and may spend more time on patient education. At Klarity Health, we credential all providers thoroughly, ensuring they’re properly licensed and authorized to prescribe in your state.

What Medications Can Be Prescribed via Telehealth?

Let’s clarify which weight loss medications are available through telehealth and how they differ.

Wegovy (Semaglutide 2.4mg)

• FDA Status: Approved specifically for chronic weight management
• Telehealth Prescribing: ✅ Fully allowed nationwide
• Schedule: Not a controlled substance
• Typical Protocol: Weekly self-injection, starting at lower doses and gradually increasing
• Important: Must be FDA-approved brand medication—compounded versions were banned by the FDA in 2025

Ozempic (Semaglutide 0.5-1mg)

• FDA Status: Approved for type 2 diabetes
• Telehealth Prescribing: ✅ Allowed, but typically prescribed off-label for weight loss
• Schedule: Not a controlled substance
• Note: Same active ingredient as Wegovy but at lower doses. Legitimate providers will document medical necessity when prescribing off-label and ensure proper informed consent.

Mounjaro (Tirzepatide)

• FDA Status: Approved for type 2 diabetes; also available as Zepbound for obesity
• Telehealth Prescribing: ✅ Fully allowed
• Schedule: Not a controlled substance
• Typical Protocol: Weekly self-injection with gradual dose escalation
• Advantage: Dual-action mechanism (GLP-1 and GIP receptor agonist) may produce greater weight loss

What About Compounded Versions?

Be cautious. In 2025, the FDA ended the emergency shortage allowance for compounded semaglutide and took enforcement action against telehealth companies selling compounded versions. Compounded GLP-1 medications are no longer widely available through legitimate telehealth services.

Why this matters: Compounded medications aren’t subject to the same FDA safety oversight as approved drugs. Stick with FDA-approved brands (Wegovy, Ozempic, Mounjaro/Zepbound) dispensed through licensed pharmacies.

Red Flags: How to Spot Questionable Telehealth Services

The popularity of weight loss medications has unfortunately attracted some less-than-reputable operators. Watch out for these warning signs:

🚩 Guaranteed Prescriptions

Any service that promises you’ll get a prescription without a thorough evaluation is a major red flag. Legitimate providers will turn away patients who don’t meet clinical criteria or have contraindications.

🚩 No Live Provider Interaction

If a service offers prescriptions based solely on a questionnaire—with no video consultation with a licensed clinician—walk away. Federal and state telehealth laws require establishing a proper patient-provider relationship.

🚩 Selling Compounded or ‘Generic’ Semaglutide

As of 2025, FDA-approved Wegovy and Ozempic should be your only options through U.S. telehealth. Be extremely wary of services offering:

• ‘Compounded semaglutide’ for weight loss
• Medications from overseas pharmacies
• Suspiciously cheap ‘generic’ versions

🚩 No Follow-Up or Monitoring

Weight loss medications require ongoing monitoring for safety and effectiveness. Services that hand out prescriptions without scheduling follow-ups aren’t providing adequate care.

🚩 Unclear Provider Credentials

Legitimate telehealth platforms clearly state:

• The provider’s name and credentials
• Which state(s) they’re licensed in
• How to contact them with questions

If this information is vague or missing, it’s a red flag.

🚩 Minimal Risk Discussion

Reputable providers will thoroughly discuss:

• Common side effects (nausea, GI issues, etc.)
• Serious risks (pancreatitis, gallbladder problems, thyroid concerns)
• Contraindications
• The importance of lifestyle changes alongside medication

If a service glosses over risks or makes weight loss sound effortless, that’s a problem.

What to Expect During Your Telehealth Appointment

Understanding the process helps you prepare and know what to expect from quality care.

Before Your Appointment

Gather Information:

• Current height and weight (measure at home)
• List of current medications and doses
• Medical history, including surgeries and major health conditions
• Family health history (especially thyroid cancer or MEN2 syndrome)
• Previous weight loss attempts and results
• Insurance information (if applicable)

Prepare Questions:

• Which medication is best for my situation?
• What results can I realistically expect?
• What are the most common side effects?
• How much will this cost? (Klarity Health offers transparent pricing for both insurance and cash-pay patients)
• What happens if I have side effects?

During the Video Consultation

Your provider will:

• Review your medical history in detail
• Calculate and discuss your BMI
• Ask about your weight loss goals and previous attempts
• Screen for contraindications
• Explain medication options, how they work, and what to expect
• Discuss the importance of diet and exercise alongside medication
• Answer your questions thoroughly
• Obtain informed consent if prescribing

Typical appointment length: 20-45 minutes for initial consultations.

After Your Appointment

If prescribed medication:

• You’ll receive an electronic prescription sent to your preferred pharmacy
• Your provider will give you instructions for administration
• You’ll schedule follow-up appointments
• Many platforms provide educational resources about your medication

First prescription tips:

• GLP-1 medications often start at low doses to minimize side effects
• Insurance coverage varies—check with your pharmacy about costs
• Most medications come with instructions and injection demonstration videos
• Side effects are typically worst in the first few weeks and improve

Follow-Up Care

Expect regular check-ins:

• First month: Often 2-4 weeks after starting to assess tolerance
• Ongoing: Every 1-3 months to monitor weight loss, adjust doses, and check for side effects
• Lab work: Periodic blood tests to ensure the medication isn’t affecting your thyroid, pancreas, or kidney function

At Klarity Health, our providers maintain availability for questions between appointments, ensuring you’re supported throughout your weight loss journey.

Insurance Coverage and Costs

One of the biggest questions patients have: How much will this cost?

Insurance Coverage

The Reality: Insurance coverage for weight loss medications is inconsistent. Some plans cover GLP-1 medications for obesity, while others don’t—or only cover them for diabetes management.

What affects coverage:

• Your specific insurance plan and state
• Whether your provider documents medical necessity properly
• Your BMI and co-existing conditions
• Prior authorization requirements

Medicare: As of 2025, traditional Medicare does not cover weight loss medications. Some Medicare Advantage plans do offer coverage.

Cash-Pay Options

Many patients pay out-of-pocket for weight loss medications. Costs vary widely:

Brand medications at retail pharmacies:

• Wegovy: $1,300-$1,500 per month without insurance
• Ozempic: $900-$1,100 per month without insurance
• Mounjaro/Zepbound: $1,000-$1,200 per month without insurance

Discount programs: Manufacturer savings cards can reduce costs significantly for eligible patients (typically those without government insurance).

Telehealth service costs: Most telehealth platforms charge for the consultation separately from medication costs:

• Initial consultations: $50-$200
• Follow-up visits: $30-$100
• Monthly subscription models: $100-$300+ (varies by service)

At Klarity Health, we believe in transparent pricing with no surprise fees. We accept both insurance and cash payment, and our team helps you understand your options upfront—including manufacturer savings programs and pharmacy discount options.

Common Questions About Telehealth Weight Loss Treatment

Do I really need to change my diet and exercise?

Yes. While GLP-1 medications are powerful, they work best—and produce the most sustainable results—when combined with lifestyle changes. These medications help control appetite and cravings, making it easier to stick with healthier eating patterns. Your provider will work with you to create realistic nutrition and activity goals.

How much weight can I expect to lose?

Clinical trials show:

• Wegovy: Average 15-20% body weight loss over 68 weeks
• Mounjaro/Zepbound: Average 15-22% body weight loss, depending on dose
• Individual results vary significantly

Most patients see gradual weight loss—typically 1-2 pounds per week once therapeutic doses are reached. Be wary of any service promising dramatic overnight results.

What if I experience side effects?

Common side effects include nausea, diarrhea, constipation, and decreased appetite. These typically improve after the first few weeks.

When to contact your provider:

• Severe or persistent vomiting
• Severe abdominal pain
• Vision changes
• Signs of pancreatitis or gallbladder problems

Reputable telehealth services (like Klarity Health) provide clear guidance on managing side effects and when to seek immediate care.

Can I switch from in-person to telehealth care?

Yes. Many patients start with a local provider and transition to telehealth for convenience. Your telehealth provider will need to review your medical records and conduct their own evaluation, but the transition is usually straightforward.

What happens if I move to a different state?

Your telehealth provider must be licensed in the state where you’re physically located during treatment. If you move, you may need to find a new provider licensed in your new state, or your current telehealth service may have providers credentialed in multiple states.

How long will I need to take these medications?

Weight loss medications are typically intended for long-term use. Many patients regain weight if they stop the medication. Your provider will discuss the pros and cons of long-term therapy and help you make informed decisions about duration.

The Future of Telehealth Weight Loss Treatment

Telehealth access to weight loss medications is expanding, not contracting. Here’s what to watch for:

Regulatory Developments

• DEA extensions: The temporary telehealth flexibilities for controlled substances are expected to continue or become permanent, reflecting regulatory acceptance of telemedicine
• State law modernization: More states are updating laws to reduce telehealth barriers
• Congressional support: Bills like the TREATS Act signal bipartisan support for expanded telehealth access

Expanded Provider Access

The number of states granting nurse practitioners full independent practice authority continues to grow (34 states + DC as of 2025), which means more telehealth providers can offer services without restrictive oversight requirements.

New Medications

Several new anti-obesity medications are in development and approaching FDA approval. Telehealth platforms will likely offer these alongside current options, giving patients more choices.

Improved Insurance Coverage

As evidence mounts for the long-term health benefits and cost-effectiveness of treating obesity with medication, insurance coverage is expected to gradually improve—though progress will be uneven across plans and states.

Finding the Right Telehealth Provider for You

When choosing a telehealth service for weight loss medication, look for:

Essential Qualities

✅ Licensed providers in your state with clear credentials
✅ Comprehensive evaluations (not just questionnaires)
✅ Transparent pricing with no hidden fees
✅ Regular follow-up and monitoring
✅ FDA-approved medications only
✅ Insurance and cash-pay options
✅ Patient support between appointments
✅ Clear policies on side effects and emergency care

Questions to Ask

Before committing to a telehealth service:

• What are the provider’s qualifications and license status?
• What’s the total cost, including consultations and medications?
• How often will I have follow-up appointments?
• What support is available if I have questions or side effects?
• Do you accept my insurance?
• What happens if the medication isn’t right for me?

Take the Next Step Toward Your Weight Loss Goals

If you’re struggling with obesity or weight-related health conditions, telehealth can provide convenient, professional access to proven weight loss medications. The key is choosing a reputable provider who prioritizes your safety and success.

At Klarity Health, we connect you with experienced, licensed providers who understand the complexities of weight management. Our platform offers:

• Provider availability across multiple states with credentials you can trust
• Transparent, upfront pricing with both insurance acceptance and cash-pay options
• Comprehensive care including initial evaluation, ongoing monitoring, and support
• Evidence-based treatment using FDA-approved medications and proven lifestyle strategies

Whether you’re just starting to explore weight loss medication or you’re ready to begin treatment, our team is here to support you with compassionate, high-quality care—delivered conveniently through telehealth.

Ready to learn more? Visit Klarity Health today to see if telehealth weight loss treatment is right for you. Your healthier future could be just a video consultation away.

Sources and References

1. DEA Announcement (November 2024) – ‘DEA and HHS Extend Telemedicine Flexibilities through 2025.’ Drug Enforcement Administration, November 15, 2024. Available at: https://www.dea.gov/documents/2024/2024-11/2024-11-15/dea-and-hhs-extend-telemedicine-flexibilities-through-2025

2. Axios News – ‘COVID-era telehealth prescribing extended.’ Axios, November 18, 2024. Available at: https://www.axios.com/2024/11/18/covid-telehealth-prescribing-extended-adderall

3. McDermott Will & Emery Legal Insights – ‘DEA Extends Telemedicine Flexibilities for Controlled Substance Prescribing Through December 31, 2025.’ November 18, 2024. Available at: https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/

4. Goodwin Procter Law Alert – ‘The Changing Regulatory and Reimbursement Landscape for Weight-Loss Drugs.’ March 27, 2024. Available at: https://www.goodwinlaw.com/en/insights/publications/2024/03/alerts-lifesciences-hltc-changing-regulatory-reimbursement-weight-loss-drugs

5. Reuters – ‘Hims to cut 4% of workforce amid ban on weight-loss drug copies.’ May 30, 2025. Available at: https://www.reuters.com/business/healthcare-pharmaceuticals/hims-cut-4-workforce-amid-ban-weight-loss-drug-copies-2025-05-30/

This article is for informational purposes only and does not constitute medical advice. Always consult with a licensed healthcare provider before starting any weight loss medication. Regulations and medical practices change over time; this information is current as of December 2025.

Source:

• https://www.axios.com/2024/11/18/covid-telehealth-prescribing-extended-adderall#:~:text=The%20Drug%20Enforcement%20Administration%20,year%20extension
• https://www.dea.gov/documents/2024/2024-11/2024-11-15/dea-and-hhs-extend-telemedicine-flexibilities-through-2025#:~:text=telemedicine%20flexibilities%20through%20December%2031%2C,HHS%20on%20November%2015%2C%202024
• https://www.mwe.com/insights/dea-signals-extension-of-telemedicine-flexibilities-for-controlled-substance-prescribing-for-2026/#:~:text=A%20new%20rule%20posted%20on,date%20of%20December%2031%2C%202025
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=,a%20final%20set%20of%20regulations
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=31%2C%202024.%20,In%20February%202023%2C%20the%20DEA
• https://www.mwe.com/insights/dea-extends-telemedicine-flexibilities-for-controlled-substance-prescribing-through-december-31-2025/#:~:text=to%20perform%20an%20in,rule%20regarding%20telemedicine%20prescribing%20of
• https://www.whitehouse.senate.gov/news/release/whitehouse-murkowski-warner-blackburn-urge-white-house-and-dea-to-extend-telehealth-flexibilities-for-substance-use-disorder-and-mental-health-treatment/#:~:text=Whitehouse%2C%20Murkowski%2C%20Warner%2C%20Blackburn%20Urge,substance%20use%20disorder%20treatment%20Washington
• https://natlawreview.com/article/arkansas-it-again-telemedicine-regulation-arkansas-undergoes-additional-change#:~:text=Arkansas%20currently%20has%20one%20of,person%20examination
• https://www.nextech.com/blog/semaglutide-laws-by-state#:~:text=Who%20can%20prescribe%20semaglutide%3F%20,
• https://natlawreview.com/article/arkansas-it-again-telemedicine-regulation-arkansas-undergoes-additional-change#:~:text=Arkansas%20currently%20has%20one%20of,encounter%20to%20establish%20a%20valid